Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6783 | 1368 | 45.6 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1347 | 7852 | ADENOSINE//ADENOSINE RECEPTORS//ADENOSINE A2A RECEPTOR |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | NEW ENGLAND INFLAMMAT TISSUE PROTECT | Address | 29 | 65% | 2% | 28 |
2 | MUCOSAL INFLAMMAT PROGRAM | Address | 27 | 38% | 4% | 55 |
3 | ADENOSINE RECEPTORS | Author keyword | 13 | 12% | 7% | 97 |
4 | ATL313 | Author keyword | 8 | 100% | 0% | 5 |
5 | ADENOSINE RECEPTOR | Author keyword | 8 | 11% | 5% | 64 |
6 | CD73 | Author keyword | 5 | 18% | 2% | 27 |
7 | A2B | Author keyword | 5 | 37% | 1% | 10 |
8 | ATL 146E | Author keyword | 4 | 67% | 0% | 4 |
9 | A2BAR | Author keyword | 4 | 75% | 0% | 3 |
10 | ATL146E | Author keyword | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ADENOSINE RECEPTORS | 13 | 12% | 7% | 97 | Search ADENOSINE+RECEPTORS | Search ADENOSINE+RECEPTORS |
2 | ATL313 | 8 | 100% | 0% | 5 | Search ATL313 | Search ATL313 |
3 | ADENOSINE RECEPTOR | 8 | 11% | 5% | 64 | Search ADENOSINE+RECEPTOR | Search ADENOSINE+RECEPTOR |
4 | CD73 | 5 | 18% | 2% | 27 | Search CD73 | Search CD73 |
5 | A2B | 5 | 37% | 1% | 10 | Search A2B | Search A2B |
6 | ATL 146E | 4 | 67% | 0% | 4 | Search ATL+146E | Search ATL+146E |
7 | A2BAR | 4 | 75% | 0% | 3 | Search A2BAR | Search A2BAR |
8 | ATL146E | 4 | 75% | 0% | 3 | Search ATL146E | Search ATL146E |
9 | A2B RECEPTOR | 3 | 28% | 1% | 8 | Search A2B+RECEPTOR | Search A2B+RECEPTOR |
10 | A2A | 3 | 23% | 1% | 10 | Search A2A | Search A2A |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DEAMINASE DEFICIENT MICE | 81 | 73% | 4% | 61 |
2 | INHALED ADENOSINE | 70 | 89% | 2% | 32 |
3 | INDUCED VASCULAR LEAK | 53 | 85% | 2% | 28 |
4 | NUCLEOTIDE PHOSPHOHYDROLYSIS | 38 | 89% | 1% | 17 |
5 | ECTO 5 NUCLEOTIDASE CD73 | 35 | 50% | 4% | 50 |
6 | INHIBITS IL 12 | 33 | 77% | 2% | 23 |
7 | A2B RECEPTORS | 26 | 34% | 5% | 62 |
8 | DEPENDENT HISTAMINE RELEASE | 22 | 66% | 2% | 21 |
9 | HIF 1 DEPENDENT REPRESSION | 19 | 70% | 1% | 16 |
10 | ORAL TERFENADINE | 15 | 56% | 1% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases | 2008 | 349 | 123 | 63% |
Ischemia and reperfusion-from mechanism to translation | 2011 | 367 | 136 | 21% |
MECHANISMS OF DISEASE Purinergic Signaling during Inflammation | 2012 | 85 | 96 | 52% |
Adenosine receptors as drug targets - what are the challenges? | 2013 | 84 | 278 | 28% |
Adenosine: an endogenous regulator of innate immunity | 2004 | 410 | 60 | 65% |
A(2B) adenosine receptors in immunity and inflammation | 2009 | 71 | 80 | 78% |
Adenosine, an endogenous distress signal, modulates tissue damage and repair | 2007 | 278 | 70 | 36% |
Adenosine: An endogenous modulator of innate immune system with therapeutic potential | 2009 | 66 | 103 | 56% |
Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology | 2010 | 56 | 85 | 42% |
Adenosine 5 '-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation | 2006 | 395 | 677 | 30% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEW ENGLAND INFLAMMAT TISSUE PROTECT | 29 | 65% | 2.0% | 28 |
2 | MUCOSAL INFLAMMAT PROGRAM | 27 | 38% | 4.0% | 55 |
3 | DRUG PHARMACOL SCI | 3 | 35% | 0.5% | 7 |
4 | DIPARTIMENTO MED INTERNA SPECIALIST | 2 | 20% | 0.7% | 10 |
5 | CARDIOVASC P SCIROBERT C BYRD HLTH SCI | 2 | 67% | 0.1% | 2 |
6 | ADV LIGHT MICROSCOPY CORE IL | 2 | 50% | 0.2% | 3 |
7 | BIOCHEM IMMUNOPHARMACOL SECT | 2 | 50% | 0.2% | 3 |
8 | ORGAN PROTECT PROGRAM | 2 | 50% | 0.2% | 3 |
9 | PHARMACEUT CARE HLTH | 2 | 50% | 0.2% | 3 |
10 | SECT OXIDAT ST S TISSUE INJURY | 2 | 14% | 0.9% | 12 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000254793 | MOL RECOGNIT SECT//A3 ADENOSINE RECEPTOR//ADENOSINE RECEPTORS |
2 | 0.0000139247 | NTPDASE//ATP DIPHOSPHOHYDROLASE//ECTO ATPASE |
3 | 0.0000094702 | DOXOFYLLINE//ENPROFYLLINE//3H IMIDAZO4 5 CQUINOLIN 45H ONE |
4 | 0.0000090360 | KW 3902//2 3 CAMP//ADENOSINE A1 RECEPTOR ANTAGONIST |
5 | 0.0000064651 | ADENOSINE PHARMACOLOGY//ANESTHESIA VOLATILE ISOFLURANE NITROUS OXIDE//NBTI SENSITIVE ADENOSINE TRANSPORTER |
6 | 0.0000057254 | ADENOSINE A2A RECEPTOR//ADENOSINE A2A RECEPTORS//ISTRADEFYLLINE |
7 | 0.0000055067 | PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY//ADENOSINE DEAMINASE//CECR1 |
8 | 0.0000054683 | RAT HEART FUNCTION//D RIBOSE//ACADESINE |
9 | 0.0000052392 | ANTIADRENERGIC//PHENYLISOPROPYLADENOSINE//DIPROPYLCYCLOPENTYLXANTHINE |
10 | 0.0000048218 | HUMAN PLACENTAL EXTRACT//PLACENTA EXTRACT//PORCINE PLACENTA EXTRACT |